These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 9531520)
1. Stereoselective metabolism of benoxaprofen in rats. Biliary excretion of benoxaprofen taurine conjugate and glucuronide. Mohri K; Okada K; Benet LZ Drug Metab Dispos; 1998 Apr; 26(4):332-7. PubMed ID: 9531520 [TBL] [Abstract][Full Text] [Related]
2. Effects of clofibric acid on the biliary excretion of benoxaprofen glucuronide and taurine conjugate in rats. Okada K; Kanoh H; Mohri K Pharmazie; 2011 Oct; 66(10):777-83. PubMed ID: 22026160 [TBL] [Abstract][Full Text] [Related]
3. HPLC-NMR with severe column overloading: fast-track metabolite identification in urine and bile samples from rat and dog treated with [14C]-ZD6126. Lenz EM; D'Souza RA; Jordan AC; King CD; Smith SM; Phillips PJ; McCormick AD; Roberts DW J Pharm Biomed Anal; 2007 Feb; 43(3):1065-77. PubMed ID: 17030109 [TBL] [Abstract][Full Text] [Related]
4. Stereoselective taurine conjugation of (R)-benoxaprofen enantiomer in rats: in vivo and in vitro studies using rat hepatic mitochondria and microsomes. Mohri K; Okada K; Benet LZ Pharm Res; 2005 Jan; 22(1):79-85. PubMed ID: 15771233 [TBL] [Abstract][Full Text] [Related]
5. Stereoselective disposition of hydratropic acid in rat. Yamaguchi T; Nakamura Y Drug Metab Dispos; 1985; 13(5):614-9. PubMed ID: 2865113 [TBL] [Abstract][Full Text] [Related]
6. Biliary excretion and enterohepatic cycling of R- and S-flurbiprofen in the rat. Eeckhoudt SL; Evrard PA; Verbeeck RK Drug Metab Dispos; 1997 Apr; 25(4):428-30. PubMed ID: 9107541 [TBL] [Abstract][Full Text] [Related]
7. Bioactivation of a toxic metabolite of valproic acid, (E)-2-propyl-2,4-pentadienoic acid, via glucuronidation. LC/MS/MS characterization of the GSH-glucuronide diconjugates. Tang W; Abbott FS Chem Res Toxicol; 1996 Mar; 9(2):517-26. PubMed ID: 8839057 [TBL] [Abstract][Full Text] [Related]
8. Biliary excretion of 17-(allylamino)-17-demethoxygeldanamycin (NSC 330507) and metabolites by Fischer 344 rats. Musser SM; Egorin MJ; Zuhowski EG; Hamburger DR; Parise RA; Covey JM; White KD; Eiseman JL Cancer Chemother Pharmacol; 2003 Aug; 52(2):139-46. PubMed ID: 12761648 [TBL] [Abstract][Full Text] [Related]
9. Identification of ractopamine hydrochloride metabolites excreted in rat bile. Smith DJ; Giddings JM; Feil VJ; Paulson GD Xenobiotica; 1995 May; 25(5):511-20. PubMed ID: 7571724 [TBL] [Abstract][Full Text] [Related]
10. Glucuronidation as a transient intermediate metabolic step in the elimination of (-)-carbovir. Identification of (-)-carbovir-5'-O-glucuronide in rat bile. Zimmerman CL; Iyer KR; Faudskar AL; Remmel RP Drug Metab Dispos; 1993; 21(5):902-10. PubMed ID: 7902254 [TBL] [Abstract][Full Text] [Related]
11. Simultaneous determination of the phase II metabolites of the non steroidal anti-inflammatory drug etodolac in human urine. Berendes U; Blaschke G Enantiomer; 1996; 1(4-6):415-22. PubMed ID: 9676278 [TBL] [Abstract][Full Text] [Related]
12. Covalent binding of acidic drugs via reactive intermediates: detection of benoxaprofen and flunoxaprofen protein adducts in biological material. Dahms M; Spahn-Langguth H Pharmazie; 1996 Nov; 51(11):874-81. PubMed ID: 8985978 [TBL] [Abstract][Full Text] [Related]
13. Effect of selective phase II enzyme inducers on glucuronidation of benoxaprofen in rats. Dong JQ; Etheridge AS; Smith PC Drug Metab Dispos; 1999 Dec; 27(12):1423-8. PubMed ID: 10570023 [TBL] [Abstract][Full Text] [Related]
14. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs. Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117 [TBL] [Abstract][Full Text] [Related]
15. A nonprimate animal model applicable to zidovudine pharmacokinetics in humans: inhibition of glucuronidation and renal excretion of zidovudine by probenecid in rats. Mays DC; Dixon KF; Balboa A; Pawluk LJ; Bauer MR; Nawoot S; Gerber N J Pharmacol Exp Ther; 1991 Dec; 259(3):1261-70. PubMed ID: 1762074 [TBL] [Abstract][Full Text] [Related]
16. Metabolism of the bisphosphonate ester U-91502 in rats. Slatter JG; Feenstra KL; Hauer MJ; Kloosterman DA; Parton AH; Sanders PE; Scott G; Speed W Drug Metab Dispos; 1996 Jan; 24(1):65-73. PubMed ID: 8825192 [TBL] [Abstract][Full Text] [Related]
17. In vivo and in vitro metabolism studies on a class III antiarrhythmic agent. Vickers S; Duncan CA; Kari PH; Homnick CF; Elliott JM; Pitzenberger SM; Hichens M; Vyas KP Drug Metab Dispos; 1993; 21(3):467-73. PubMed ID: 8100503 [TBL] [Abstract][Full Text] [Related]
18. Metabolism and excretion of trovafloxacin, a new quinolone antibiotic, in Sprague-Dawley rats and beagle dogs. Effect of bile duct cannulation on excretion pathways. Dalvie DK; Khosla NB; Navetta KA; Brighty KE Drug Metab Dispos; 1996 Nov; 24(11):1231-40. PubMed ID: 8937858 [TBL] [Abstract][Full Text] [Related]
19. Toxicokinetics and metabolism of 1,2-diethylbenzene in male Sprague Dawley rats--part 2: evidence for in vitro and in vivo stereoselectivity of 1,2-diethylbenzene metabolism. Payan JP; Cossec B; Beydon D; Fabry JP; Ferrari E Drug Metab Dispos; 2001 Jun; 29(6):868-76. PubMed ID: 11353756 [TBL] [Abstract][Full Text] [Related]
20. Study on the stereoselective excretion of tetrahydropalmatine enantiomers in rats and identification of in vivo metabolites by liquid chromatography-tandem mass spectrometry. Hong Z; Wen J; Zhang Q; Fan G; Chai Y; Wu Y Chirality; 2010 Mar; 22(3):355-60. PubMed ID: 19544352 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]